ExonHit Therapeutics SA, a French drug and diagnostic company, has announced that Loic Maurel, M.D., will become its chief operating officer on 1 July 2008 and subsequently also become the company’s chief executive. Dr Maurel was previously the president and CEO of Debiovision Inc, a Canadian pharmaceutical development company.
ExonHit specialises in the analysis of alternative RNA splicing.
Source
ExonHit press release, 4 June 2008
Copyright Evernow Publishing 2008